Immunotherapy is among the newest and most potent weapons against cancer. It prompts the immune system to recognize tumors as intruders in the body and attack. But not all patients respond well to immunotherapy. Why? Scientists aren’t always sure.
UMD researcher aims to uncover “ghost networks” in Medicare Advantage health insurance plans
Dr. Mika Hamer is about to go ghost hunting. Thanks to a $100K grant from the Robert Johnson Wood Foundation (RWJF), the University of Maryland